PeopleBio, Inc. (KOSDAQ:304840)
South Korea
· Delayed Price · Currency is KRW 1,530.00
-30.00 (-1.92%)
At close: Dec 5, 2025
PeopleBio Revenue
PeopleBio had revenue of 1.18B KRW in the quarter ending September 30, 2025, with 23.20% growth. This brings the company's revenue in the last twelve months to 3.36B, down -23.26% year-over-year. In the year 2024, PeopleBio had annual revenue of 3.73B, down -16.20%.
Revenue (ttm)
3.36B
Revenue Growth
-23.26%
P/S Ratio
9.65
Revenue / Employee
72.94M
Employees
n/a
Market Cap
32.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.73B | -721.35M | -16.20% |
| Dec 31, 2023 | 4.45B | 8.02M | 0.18% |
| Dec 31, 2022 | 4.44B | 3.87B | 670.22% |
| Dec 31, 2021 | 577.08M | 69.23M | 13.63% |
| Dec 31, 2020 | 507.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| HD Hyundai Heavy Industries | 16.39T |
| KB Financial Group | 14.89T |